Pharvaris
SaraBeth Hahn, PharmD, RPh, currently serves as the Vice President and Global Head of Regulatory Affairs & Quality at Pharvaris since April 2023. Prior to this role, SaraBeth held the position of Vice President of Regulatory Affairs at Krystal Biotech, Inc., and held various leadership roles at Acceleron Pharma over a span of four years. SaraBeth's experience includes serving as a COVID Vaccination Specialist at Cataldo Ambulance Service Inc. and a Global Regulatory Lead for Rare Diseases at Sanofi Genzyme, among other roles in regulatory affairs. Educational credentials include a PharmD from Northeastern University, a Master in Liberal Arts with a focus on Biotechnology and management principles from Harvard University, and additional studies at Harvard Medical School.
This person is not in any teams
This person is not in any offices
Pharvaris
2 followers
Pharvaris is a preclinical stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients for use as an alternative to injected therapies for hereditary angioedema (HAE) and other B2 receptor-mediated indications. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.